"World's Most Complete Market Research Reports Repository"

Global Human Growth Hormone Drugs Market Research Report 2011-2023

Summary
The global Human Growth Hormone Drugs market will reach xxx Million USD in 2018 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Norditropin
1.2.1.2 Genotropin
1.2.1.3 Humatrope
1.2.1.4 Saizen
1.2.1.5 Omnitrope - the Somatropin Biosimilar
1.2.1.6 Somatropin Biopartners
1.2.2 by Application
1.2.2.1 Prader-Willi Syndrome
1.2.2.2 Turner Syndrome
1.2.2.3 Short Stature Homeobox Gene
1.2.2.4 Small for Gestational Age
1.2.2.5 Chronic Renal Insufficiency
1.2.2.6 Short Bowel Syndrome
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Norditropin Market, 2011-2016
4.1.2 Genotropin Market, 2011-2016
4.1.3 Humatrope Market, 2011-2016
4.1.4 Saizen Market, 2011-2016
4.1.5 Omnitrope - the Somatropin Biosimilar Market, 2011-2016
4.1.6 Somatropin Biopartners Market, 2011-2016
4.2 Market Forecast
4.2.1 Norditropin Market Forecast, 2017-2022
4.2.2 Genotropin Market Forecast, 2017-2022
4.2.3 Humatrope Market Forecast, 2017-2022
4.2.4 Saizen Market Forecast, 2017-2022
4.2.5 Omnitrope - the Somatropin Biosimilar Market Forecast, 2017-2022
4.2.6 Somatropin Biopartners Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Prader-Willi Syndrome Market, 2011-2016
5.1.2 Turner Syndrome Market, 2011-2016
5.1.3 Short Stature Homeobox Gene Market, 2011-2016
5.1.4 Small for Gestational Age Market, 2011-2016
5.1.5 Chronic Renal Insufficiency Market, 2011-2016
5.1.6 Short Bowel Syndrome Market, 2011-2016
5.2 Market Forecast
5.2.1 Prader-Willi Syndrome Market Forecast, 2017-2022
5.2.2 Turner Syndrome Market Forecast, 2017-2022
5.2.3 Short Stature Homeobox Gene Market Forecast, 2017-2022
5.2.4 Small for Gestational Age Market Forecast, 2017-2022
5.2.5 Chronic Renal Insufficiency Market Forecast, 2017-2022
5.2.6 Short Bowel Syndrome Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Eli Lilly and Company (US)
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Ferring Holding SA (Switzerland)
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Genentech, Inc. (US)
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 GeneScience Pharmaceuticals Co., Ltd. (China)
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Merck KgaA (Germany)
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Novo Nordisk A/S (Denmark)
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Pfizer, Inc. (US)
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Sandoz International GmbH (Germany)
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion

Table Product Specifications of Human Growth Hormone Drugs
Table Products Segment of Human Growth Hormone Drugs
Table Norditropin Overview
Table Genotropin Overview
Table Humatrope Overview
Table Saizen Overview
Table Omnitrope - the Somatropin Biosimilar Overview
Table Somatropin Biopartners Overview
Table Global Human Growth Hormone Drugs Market by Type, 2011-2022 (USD Million)
Table Application Segment of Human Growth Hormone Drugs
Table Prader-Willi Syndrome Overview
Table Turner Syndrome Overview
Table Short Stature Homeobox Gene Overview
Table Small for Gestational Age Overview
Table Chronic Renal Insufficiency Overview
Table Short Bowel Syndrome Overview
Table Global Human Growth Hormone Drugs Market by Application, 2011-2022 (USD Million)
Table Global Human Growth Hormone Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Human Growth Hormone Drugs
Table Market Dynamics
Table Policy of Human Growth Hormone Drugs
Table GDP of Major Countries
Table Norditropin CAGR by Revenue and Volume, 2011-2016
Table Genotropin CAGR by Revenue and Volume, 2011-2016
Table Humatrope CAGR by Revenue and Volume, 2011-2016
Table Saizen CAGR by Revenue and Volume, 2011-2016
Table Omnitrope - the Somatropin Biosimilar CAGR by Revenue and Volume, 2011-2016
Table Somatropin Biopartners CAGR by Revenue and Volume, 2011-2016
Table Norditropin CAGR by Revenue and Volume, 2012-2022
Table Genotropin CAGR by Revenue and Volume, 2012-2022
Table Humatrope CAGR by Revenue and Volume, 2012-2022
Table Saizen CAGR by Revenue and Volume, 2012-2022
Table Omnitrope - the Somatropin Biosimilar CAGR by Revenue and Volume, 2012-2022
Table Somatropin Biopartners CAGR by Revenue and Volume, 2012-2022
Table Prader-Willi Syndrome CAGR by Revenue and Volume, 2011-2016
Table Turner Syndrome CAGR by Revenue and Volume, 2011-2016
Table Short Stature Homeobox Gene CAGR by Revenue and Volume, 2011-2016
Table Small for Gestational Age CAGR by Revenue and Volume, 2011-2016
Table Chronic Renal Insufficiency CAGR by Revenue and Volume, 2011-2016
Table Short Bowel Syndrome CAGR by Revenue and Volume, 2011-2016

Choose License Type